Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL18044662

Clc1ncnc2c1c(I)cn2C1CCNCC1.O=C(O)C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADK P55263 6/20 0.44
▸ SLC29A1 Q99808 1/20 0.44
▸ FGR P09769 1/20 0.39
▸ EPHA1 P21709 1/20 0.39
▸ TXK P42681 1/20 0.39
▸ FRK P42685 1/20 0.39
▸ PTK6 Q13882 1/20 0.39
▸ SRC P12931 7/20 0.38
▸ LCK P06239 2/20 0.38
▸ TEK Q02763 1/20 0.38
▸ EGFR P00533 4/20 0.37
▸ ABL1 P00519 3/20 0.36
▸ ABL2 P42684 2/20 0.36
▸ HASPIN Q8TF76 1/20 0.35
▸ PIM1 P11309 2/20 0.34
▸ PIM3 Q86V86 2/20 0.34
▸ PIM2 Q9P1W9 2/20 0.34
▸ MTOR P42345 2/20 0.33
▸ PIK3CD O00329 1/20 0.33
▸ HCK P08631 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6865980 0.89 ADK (0.50) ADKSLC29A1FGREPHA1TXK
SCHEMBL15739516 0.81 SRC (0.50) ADKSLC29A1FGREPHA1TXK
Tert-Butyl Formate SCHEMBL27864305 0.81 ADK (0.42) ADKSLC29A1FGREPHA1TXK
SCHEMBL16236390 0.79 ADK (0.54) ADKSLC29A1SRCLCKEGFR
SCHEMBL29484542 0.79 ADK (0.54) ADKSLC29A1SRCLCKEGFR
SCHEMBL1442273 0.78 ADK (0.47) ADKSLC29A1SRCLCKEGFR
SCHEMBL1939761 0.77 ADK (0.52) ADKSLC29A1SRCLCKTEK
SCHEMBL401328 0.77 ADK (0.52) ADKSLC29A1SRCLCKEGFR
Acetic Acid SCHEMBL30180706 0.77 ADK (0.51) ADKSLC29A1SRCHASPINMTOR
SCHEMBL30143841 0.77 SRC (0.54) FGREPHA1TXKFRKPTK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3067356-B1 PYRROLO PYRIMIDINE DERIVATIVE ONO PHARMACEUTICAL CO (JP) 2018-07-04 — — EP disclosed
US-9586967-B2 Pyrrolo pyrimidine derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2017-03-07 — — US disclosed
US-20160264579-A1 PYRROLO PYRIMIDINE DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2016-09-15 — — US disclosed
EP-3067356-A1 PYRROLO PYRIMIDINE DERIVATIVE ONO Pharmaceutical Co., Ltd. (JP) 2016-09-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160264579-A1 PYRROLO PYRIMIDINE DERIVATIVE AXL, FLT3, TYRO3 ADK 282/4885SLC29A1 3249/4885FGR 100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback